Literature DB >> 1473102

Sulfated sialyl-oligosaccharides derived from tracheobronchial mucous glycoproteins of a patient suffering from cystic fibrosis.

T P Mawhinney1, D C Landrum, D A Gayer, G J Barbero.   

Abstract

Thirteen novel oligosaccharides, each possessing both a sulfate ester and a sialic acid residue, were isolated from tracheobronchial mucous glycoproteins from a patient with cystic fibrosis via cleavage by alkaline borohydride treatment, and by employing immobilized Limulus polyphemus lectin affinity chromatography, SynChroprep AX300 anion-exchange chromatography, Bio-Gel P-2 size-exclusion chromatography, and Hypersil 120A APS-2 high-performance liquid chromatography (HPLC). Proposed structures for the resulting purified sulfated sialyl-oligosaccharides were based on carbohydrate/permethylation analyses, periodate oxidation, complete sequential exoglycosidase digestion, analysis of desulfated products and, analysis by positive-ion fast-atom-bombardment mass spectrometry (FABMS). Sulfate esters on these sialyl-oligosaccharides resided on C-6 of a terminal or an internal D-galactose or 2-acetamido-2-deoxy-D-glucose residue or C-4 of a terminal D-galactose residue. The sialic acid residues were found to be either bound (2-->6)-alpha to 2-acetamido-2-deoxy-D-galactitol or (2-->3)-alpha or (2-->6)-alpha to a D-galactose residue occupying a nonreducing terminus. For this group of oligosaccharides, ranging in size from tri- to hepta-saccharides, it was also observed that a sialic acid residue and a sulfate ester did not residue on the same oligosaccharide branch when more than one branch existed. On linear unbranched sulfated sialyl-oligosaccharides, the sialic acid residue was bound to a D-galactose residue occupying a nonreducing terminus with the sulfate ester residing on an internal D-galactose or a 2-acetamido-2-deoxy-D-glucose residue. These results demonstrate that it is possible for sialic acid and a sulfate ester to exist on the same oligosaccharide and that this oligosaccharide can be as small as a trisaccharide.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1473102     DOI: 10.1016/0008-6215(92)80087-h

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  11 in total

1.  Synthesis of sulfated oligosaccharides by cystic fibrosis trachea epithelial cells.

Authors:  J Mendicino; S Sangadala
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

Review 2.  Structure, biosynthesis, and function of salivary mucins.

Authors:  A M Wu; G Csako; A Herp
Journal:  Mol Cell Biochem       Date:  1994-08-17       Impact factor: 3.396

Review 3.  Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis.

Authors:  G Lamblin; S Degroote; J M Perini; P Delmotte; A Scharfman; M Davril; J M Lo-Guidice; N Houdret; V Dumur; A Klein; P Rousse
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

4.  Identification of two highly sialylated human tear-fluid DMBT1 isoforms: the major high-molecular-mass glycoproteins in human tears.

Authors:  Benjamin L Schulz; David Oxley; Nicolle H Packer; Niclas G Karlsson
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

5.  Pseudomonas aeruginosa mucoid strain 8830 binds glycans containing the sialyl-Lewis x epitope.

Authors:  Baoyun Xia; Goverdhan P Sachdev; Richard D Cummings
Journal:  Glycoconj J       Date:  2007-01       Impact factor: 2.916

6.  Molecular characterization of the large heavily glycosylated domain glycopeptide from the rat small intestinal Muc2 mucin.

Authors:  N G Karlsson; M E Johansson; N Asker; H Karlsson; S J Gendler; I Carlstedt; G C Hansson
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

7.  Structures of sulfated oligosaccharides isolated from the respiratory mucins of a non-secretor (O, Le(a + b -)) patient suffering from chronic bronchitis.

Authors:  J M Lo-Guidice; H Herz; G Lamblin; Y Plancke; P Roussel; M Lhermitte
Journal:  Glycoconj J       Date:  1997-01       Impact factor: 2.916

8.  Different O-glycosylation of respiratory mucin glycopeptides from a patient with cystic fibrosis.

Authors:  K A Thomsson; I Carlstedt; N G Karlsson; H Karlsson; G C Hansson
Journal:  Glycoconj J       Date:  1998-08       Impact factor: 2.916

9.  Use of sialylated or sulfated derivatives and acrylamide copolymers of Gal beta 1,3GalNAc alpha- and GalNAc alpha- to determine the specificities of blood group T- and Tn-specific lectins and the copolymers to measure anti-T and anti-Tn antibody levels in cancer patients.

Authors:  Y Chen; R K Jain; E V Chandrasekaran; K L Matta
Journal:  Glycoconj J       Date:  1995-02       Impact factor: 2.916

10.  Extracting glycan motifs using a biochemicallyweighted kernel.

Authors:  Hao Jiang; Kiyoko F Aoki-Kinoshita; Wai-Ki Ching
Journal:  Bioinformation       Date:  2011-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.